Observations from clinical settings and a wealth of data from animal studies consistently demonstrate that the primary effector molecule of RAS in cancer—particularly AngII—can directly promote tumor growth and dissemination by significantly stimulating angiogenesis [64,65]. The gene discussed is AGT; the disease is neoplasm.